Most cited article - PubMed ID 35871357
Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high-risk cytogenetics: IKEMA subgroup analysis
European journal of haematology.
2022 Nov ;
109 (5) :
504-512.
[epub] 20220818
Haematologica.
2022 Oct 01 ;
107 (10) :
2485-2491.
[epub] 20221001
- MeSH
- Dexamethasone therapeutic use MeSH
- Antibodies, Monoclonal, Humanized therapeutic use MeSH
- Humans MeSH
- Neoplasm Recurrence, Local chemically induced drug therapy MeSH
- Multiple Myeloma * drug therapy MeSH
- Neoplasms, Plasma Cell * MeSH
- Antineoplastic Combined Chemotherapy Protocols MeSH
- Thalidomide therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Dexamethasone MeSH
- Antibodies, Monoclonal, Humanized MeSH
- isatuximab MeSH Browser
- Thalidomide MeSH
